Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro- and hypopharynx: Prognostic impact may depend on type of treatment and stage of disease

被引:87
作者
Distel, Luitpold V. [1 ]
Fickenscher, Rainer [1 ,4 ]
Dietel, Katrin [1 ]
Hung, Alexander [1 ,4 ]
Iro, Heiner [2 ]
Zenk, Johannes [2 ]
Nkenke, Emeka [3 ]
Buettner, Maike [4 ]
Niedobitek, Gerald [4 ]
Grabenbauer, Gerhard G. [1 ]
机构
[1] Friedrich Alexander Univ Erlangen Nuremberg, Dept Radiat Oncol, Univ Hosp, D-91054 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nuremberg, Dept Head & Neck Surg, D-91054 Erlangen, Germany
[3] Friedrich Alexander Univ Erlangen Nuremberg, Dept Oral & Maxillofacial Surg, D-91054 Erlangen, Germany
[4] Friedrich Alexander Univ Erlangen Nuremberg, Inst Pathol, D-91054 Erlangen, Germany
关键词
Oropharyngeal carcinoma; Tumour infiltrating lymphocytes (TIL); Prognostic factors; CD8; CD20; REGULATORY T-CELLS; NECK-CANCER; STEREOTACTIC RADIOTHERAPY; PERIPHERAL-CIRCULATION; OVARIAN-CANCER; ADVANCED HEAD; LYMPHOMA; SURVIVAL; TRIAL;
D O I
10.1016/j.oraloncology.2009.05.640
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to evaluate the prognostic influence of various subtypes of tumour infiltrating lymphocytes (TIL) in head and neck cancer, in particular the potential influence of regulatory T cells (Treg) in relation to different treatment modalities was addressed. A total of 115 patients with squamous cell carcinoma of the oro- and hypopharynx were selected. A low-risk group of 62 patients with early disease was treated by primary surgery followed by external radiotherapy. A high-risk group of 53 inoperable patients with advanced disease was treated by primary radiochemotherapy. Two-hundred and forty biopsy samples were evaluated by use of the tissue-microarray technique employing the following markers: CD3, CD4, CD8, CD20, CD68, FOXP3, Granzyme B. In the low-risk group high CD20(+) infiltration was associated with a significantly better NED-survival rate (p = 0.02). Contrary, among high-risk patients low CD20+ counts indicated significantly better survival (p = 0.03). Additionally, in the low-risk group higher numbers of intraepithelial CD8(+) TIL (>66.6%) led to improved NED-survival of 95% vs. 52% (p = 0.005). The impact of TIL on prognosis in patients with head and neck cancer may be affected by type of treatment and stage of disease. This finding will influence future studies on the role of TIL in human cancers. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:E167 / E174
页数:8
相关论文
共 25 条
  • [1] Alterations in the T-Cell receptor variable gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck
    Albers, AE
    Visus, C
    Tsukishiro, T
    Ferris, RL
    Gooding, W
    Whiteside, TL
    De Leo, AB
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (08) : 2394 - 2403
  • [2] Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells
    Alvaro, T
    Lejeune, M
    Salvadó, MT
    Bosch, R
    García, JF
    Jaén, J
    Banham, AH
    Roncador, G
    Montalbán, C
    Piris, MA
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1467 - 1473
  • [3] Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers
    Badoual, C
    Hans, S
    Rodriguez, J
    Peyrard, S
    Klein, C
    Agueznay, NE
    Mosseri, V
    Laccourreye, O
    Bruneval, P
    Fridman, WH
    Brasnu, DF
    Tartour, E
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (02) : 465 - 472
  • [4] Cancer - An inflammatory link
    Balkwill, F
    Coussens, LM
    [J]. NATURE, 2004, 431 (7007) : 405 - 406
  • [5] Molecular verification of stereotactic radiotherapy in rats using ATMpS1981 immunofluorescence
    Brunner, TB
    Ernst-Stecken, A
    Jeske, I
    Grabenbauer, GG
    Sauer, R
    Distel, L
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 79 (01) : 109 - 114
  • [6] Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German cancer society 95-06 prospective randomized trial
    Budach, V
    Stuschke, M
    Budach, W
    Baumann, M
    Geismar, D
    Grabenbauer, G
    Lammert, I
    Jahnke, K
    Stueben, G
    Herrmann, T
    Bamberg, M
    Wust, P
    Hinkelbein, W
    Wernecke, KD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1125 - 1135
  • [7] Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan
    Chien, Chih-Yen
    Su, Chih-Ying
    Fang, Fu-Min
    Huang, Hsuang-Ying
    Chuang, Hui-Ching
    Chen, Ching-Mei
    Huang, Chao-Cheng
    [J]. ORAL ONCOLOGY, 2008, 44 (02) : 174 - 179
  • [8] Relationships between regulatory T cells and CD8+effector populations in patients with squamous cell carcinoma of the head and neck
    Chikamatsu, Kazuaki
    Sakakura, Koichi
    Whiteside, Theresa L.
    Furuya, Nobuhiko
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (02): : 120 - 127
  • [9] Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
    Curiel, TJ
    Coukos, G
    Zou, LH
    Alvarez, X
    Cheng, P
    Mottram, P
    Evdemon-Hogan, M
    Conejo-Garcia, JR
    Zhang, L
    Burow, M
    Zhu, Y
    Wei, S
    Kryczek, I
    Daniel, B
    Gordon, A
    Myers, L
    Lackner, A
    Disis, ML
    Knutson, KL
    Chen, LP
    Zou, WP
    [J]. NATURE MEDICINE, 2004, 10 (09) : 942 - 949
  • [10] Individual differences in chromosomal aberrations after in vitro irradiation of cells from healthy individuals, cancer and cancer susceptibility syndrome patients
    Distel, Luitpold V. R.
    Neubauer, Susann
    Keller, Ulrike
    Sprung, Carl N.
    Sauer, Rolf
    Grabenbauer, Gerhard G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 (03) : 257 - 263